NCT00572975View on ClinicalTrials.gov

Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Cystic FibrosisPancreatic Insufficiency
Interventions
OTHER

Pentadecanoic acid (PA) and Triheptadecanoin (THA)

"Two fats (Pentadecanoic acid and Triheptadecanoin) are administered in a breakfast shake for the purposes of determining malabsorption.~in breakfast shake x1"

Trial Locations (1)

19104-4399

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT00572975 - Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea | Biotech Hunter | Biotech Hunter